MBX
Price
$24.07
Change
-$0.53 (-2.15%)
Updated
Nov 13 closing price
Capitalization
1.08B
Intraday BUY SELL Signals
NEVPF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
45.13M
Intraday BUY SELL Signals
Interact to see
Advertisement

MBX vs NEVPF

Header iconMBX vs NEVPF Comparison
Open Charts MBX vs NEVPFBanner chart's image
MBX Biosciences
Price$24.07
Change-$0.53 (-2.15%)
Volume$696.01K
Capitalization1.08B
Abliva AB
PriceLoading...
Change-$0.00 (-0.00%)
Volume$58.9K
Capitalization45.13M
MBX vs NEVPF Comparison Chart in %
MBX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MBX vs. NEVPF commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBX is a Hold and NEVPF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (MBX: $24.07 vs. NEVPF: $0.03)
Brand notoriety: MBX and NEVPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MBX: 43% vs. NEVPF: 100%
Market capitalization -- MBX: $1.08B vs. NEVPF: $45.13M
MBX [@Biotechnology] is valued at $1.08B. NEVPF’s [@Biotechnology] market capitalization is $45.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MBX’s FA Score shows that 0 FA rating(s) are green whileNEVPF’s FA Score has 0 green FA rating(s).

  • MBX’s FA Score: 0 green, 5 red.
  • NEVPF’s FA Score: 0 green, 5 red.
According to our system of comparison, MBX is a better buy in the long-term than NEVPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MBX’s TA Score shows that 4 TA indicator(s) are bullish while NEVPF’s TA Score has 1 bullish TA indicator(s).

  • MBX’s TA Score: 4 bullish, 4 bearish.
  • NEVPF’s TA Score: 1 bullish, 0 bearish.
According to our system of comparison, NEVPF is a better buy in the short-term than MBX.

Price Growth

MBX (@Biotechnology) experienced а -2.71% price change this week, while NEVPF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MBX($1.08B) has a higher market cap than NEVPF($45.1M). MBX YTD gains are higher at: 33.478 vs. NEVPF (-22.222). MBX (-86.29M) and NEVPF (-87.99M) have comparable annual earnings (EBITDA) . MBX has more cash in the bank: 225M vs. NEVPF (32.7M). MBX (0) and NEVPF (0) have equivalent revenues.
MBXNEVPFMBX / NEVPF
Capitalization1.08B45.1M2,399%
EBITDA-86.29M-87.99M98%
Gain YTD33.478-22.222-151%
P/E Ratio3.14N/A-
Revenue00-
Total Cash225M32.7M688%
Total Debt650KN/A-
FUNDAMENTALS RATINGS
NEVPF: Fundamental Ratings
NEVPF
OUTLOOK RATING
1..100
40
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
10

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MBXNEVPF
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
13%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
13%
Advances
ODDS (%)
Bullish Trend 8 days ago
90%
N/A
Declines
ODDS (%)
Bearish Trend 29 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MBX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBPBX52.600.21
+0.40%
Neuberger Berman Large Cap Value Adv
BIIEX28.090.05
+0.18%
Brandes International Equity I
TINGX26.500.04
+0.15%
Thornburg International Growth I
AALIX13.440.01
+0.07%
Cavanal Hill Hedged Equity Income A
ADOCX19.28-0.11
-0.57%
Alger Dynamic Opportunities C

MBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBX has been loosely correlated with KOD. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MBX jumps, then KOD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBX
1D Price
Change %
MBX100%
-1.24%
KOD - MBX
45%
Loosely correlated
+3.16%
QLGN - MBX
41%
Loosely correlated
+1.15%
NEVPF - MBX
40%
Loosely correlated
N/A
HOWL - MBX
34%
Loosely correlated
-3.54%
VTYX - MBX
33%
Loosely correlated
+0.85%
More